CD8A and hepatocellular carcinoma: When non-cytotoxic concentrations of RES were used to treat hepatocellular carcinoma mice, RES was found to enhance anti-tumor immunity by reducing levels of Tregs and M2 macrophages and up-regulating levels of CD8+ T cells (95).